Jun. 25 at 9:06 PM
$VERA Also, Vor Bio’s massive dilution to facilitate Remegen deal. Vor Bio will issue prefunded warrants to purchase an aggregate of 700,000,000 shares of common stock at a purchase price of
$0.25 per Warrant.
The PIPE included a syndicate of world-class investors including Vor Bio’s existing stockholder RA Capital Management, as well as Mingxin Capital, Forbion, Venrock Healthcare Capital Partners, Caligan Partners and NEXTBio.
